The refolding of different α-fetoprotein variants

Protein Science

Volumn 15, Issue 9, 2006, Pages 2040-2050

  Leong, Susanna S J ^a,b   Middelberg, Anton P J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

fetoprotein; Glycosylation; Oxidative; Protein; Refolding; Renaturation

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CELL INCLUSION; CIRCULAR DICHROISM; CONTROLLED STUDY; DIALYSIS; DILUTION; DISULFIDE BOND; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; PARALLEL DESIGN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; PROTEIN TERTIARY STRUCTURE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS;

ALPHA-FETOPROTEINS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FETAL BLOOD; GLYCOSYLATION; GOATS; HUMANS; INCLUSION BODIES; MILK; PROTEIN FOLDING; PROTEIN RENATURATION;

EID: 33748126248     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.062262406     Document Type: Article

References (34)

1. Berde, C.B., Nagai, M., and Deutsch, H.F. 1979. Human α-fetoprotein: Fluorescence studies on binding and proximity relationships for fatty acids and bilirubin. J. Biol. Chem. 254: 12609-12614.
2. Boismenu, R., Semeniuk, D., and Murgita, R.A. 1997. Purification and characterization of human and mouse recombinant α-fetoproteins expressed in Escherichia coli. Protein Expr. Purif. 10: 10-26.
3. Carlsson, R.N.K., Estes, T., Degroot, J., Holden, J.T., and Ruoslahti, E. 1980. High affinity of α-fetoprotein for arachidonate and other fatty acids. Biochem. J. 190: 301-305.
4. Clark, E.D.B. 1998. Refolding of recombinant proteins. Curr. Opin. Biotechnol. 9: 157-163.
5. Cronan Jr., J.E. and Rock, C.O. 1987. Biosynthesis of membrane lipids. In Escherichia coli and Salmonella typhimurium: Cellular and molecular biology (eds. F.C. Neidhardt et al.), Vol. 1, pp. 474-497. American Society for Microbiology, Washington, DC.
6. Elbein, A.D. 1991. The role of N-linked oligosaccharides in glycoprotein function. Trends Biotechnol. 9: 346-352.
7. Gillespie, J.R. and Uversky, V.N. 2000. Structure and function of α-fetoprotein: A biophysical overview. Biochim. Biophys. Acta 1480: 41-56.
8. Hsia, J.C., Er, J.S., Tan, C.T., Ester, T., and Ruoslahti, E. 1980. α-Fetoprotein binding specificity for arachidonate, bilirubin, docosahexaenoate, and palmitate: A spin label study. J. Biol. Chem. 255: 4224-4227.
9. Janzen, R. and Tamaoki, T. 1983. Secretion and glycosylation of α-foetoprotein by the mouse yolk sac. Biochem. J. 212: 313-320.
10. Kim, Y.J., Park, S., Oh, Y.K., Kang, W., Kim, H.S., and Lee, E.Y. 2005. Purification and characterization of human caseinomacropeptide produced by a recombinant Saccharomyces cerevisiae. Protein Expr. Purif. 41: 441-446.
11. Konishi, Y., Ooi, T., and Scheraga, H.A. 1982. Regeneration of ribonuclease A from the reduced protein: Rate limiting steps. Biochemistry 21: 4734-4740.
12. 1-antitrypsin toward urea denaturation and thermal deactivation. Biochim. Biophys. Acta 1335: 265-272.
13. Leong, S.S.J. and Middelberg, A.P.J. 2006. Dilution versus dialysis: A quantitative study of the oxidative refolding of recombinant human alpha-fetoprotein. Trans IChemE, Part C, Food Bioprod. Process. 84: 9-17.
14. Levine, A.D., Rangwala, S.H., Horn, N.A., Peel, M.A., Matthews, B.K., Leimgruber, R.M., Manning, J.A., Bishop, B.F., and Olins, P.O. 1998. High level expression and refolding of mouse interleukin 4 synthesized in Escherichia coli. J. Biol. Chem. 270: 7445-7452.
15. Li, J., Zhang, S., and Wang, C.C. 2001. Only the reduced conformer of α-lactalbumin is inducible to aggregation by protein aggregates. J. Biochem. 129: 821-826.
16. Lyles, M.L. and Gilbert, H.F. 1991. Catalysis of the oxidative folding of ribonuclease A by protein disulfide isomerase: Dependence of the rate on the composition of the redox buffer. Biochemistry 30: 613-619.
17. Maachupalli-Reddy, J., Kelly, B.D., and Clark, E.D.B. 1997. Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme. Biotechnol. Prog. 13: 144-150.
18. Magnuson, K., Jackowski, S., Rock, C.O., and Cronan Jr., J.E. 1993. Regulation of fatty acid biosynthesis in Escherichia coli. Microbiol. Rev. 57: 522-542.
19. Middelberg, A.P.J. 2002. Preparative protein refolding. Trends Biotechnol. 20: 437-443.
20. Morinaga, T., Sakai, M., Wegmann, T.G., and Tamaoki, T. 1983. Primary structures of human α-fetoprotein and its mRNA. Proc. Natl. Acad. Sci. 80: 4604-4608.
21. Nacka, F., Chobert, J.M., Burova, T., Leonil, J., and Haertle, T. 1998. Induction of new physicochemical and functional properties by the glycosylation of whey proteins. J. Protein Chem. 17: 495-503.
22. Otvos, L., Urge, L., and Thurin, J. 1992. Influence of different N-linked and O-linked carbohydrates on the retention times of synthetic peptides in reversed-phase high-performance liquid-chromatography. J. Chromatogr. 599: 43-49.
23. Parker, M.H., Birck-Wilson, E., Allard, G., Masiello, N., Day, M., Murphy, K.P., Paragas, V., Silver, S., and Moody, M.D. 2004. Purification and characterisation of a recombinant version of human α-fetoprotein expressed in the milk of transgenic goats. Protein Expr. Purif. 38: 177-183.
24. Parmelee, D.C., Evenson, M.A., and Deutsch, H.F. 1978. The presence of fatty acids in human α-fetoprotein. J. Biol. Chem. 253: 2114-2119.
25. Pattanaik, P., Adiga, P.R., and Visweswariah, S.S. 1998. Refolding of native and recombinant chicken riboflavin carrier (or binding) protein: Evidence for the formation of non-native intermediates during the generation of active protein. Eur. J. Biochem. 258: 411-418.
26. Saxena, V.P. and Wetlaufer, D.B. 1970. Formation of three-dimensional structure in proteins: I. Rapid nonenzymic reactivation of reduced lysozyme. Biochemistry 25: 5015-5023.
27. Schuler, M.L. and Kargi, F. 1992. Utilizing genetically engineered organisms. In Bioprocess engineering: Basic concepts, pp. 395-430. Prentice-Hall, Englewood Cliffs, NJ.
28. Semeniuk, D.J., Boismenu, R., Tam, J., Weissenhofer, W., and Murgita, R.A. 1995. Evidence that immunosuppression is an intrinsic property of the α-fetoprotein molecule. Adv. Exp. Med. Biol. 383: 255-269.
29. Shire, S.J., Bock, L., Ogez, J., Builder, S., Kleid, D., and Moore, D.M. 1984. Purification and immunogenicity of fusion VP1 protein of food and mouth disease virus. Biochemistry 23: 6474-6480.
30. Strickland, E.H. 1974. Aromatic contributions to circular dichroism spectra of proteins. CRC Crit. Rev. Biochem. 2: 113-175.
31. Torres, J.M., Anel, A., and Uriel, J. 1992. α-Fetoprotein-mediated uptake of fatty acids by human T lymphocytes. J. Cell. Physiol. 150: 456-462.
32. Uversky, V.N., Narizhnevam, N.V., Ivanova, T.V., and Tomashevski, A.Y. 1997. Rigidity of human α-fetoprotein tertiary structure is under ligand control. Biochemistry 36: 13638-13645.
33. West, C.M. 1986. Current ideas on the significance of protein glycosylation. Mol. Cell. Biochem. 72: 3-20.
34. Woody, R.W. 1994. Circular dichroism of peptide and proteins. In Circular dichroism: Principles and applications (eds. K. Nakanishi et al.) pp. 473-496. VCH, NY.